Jason Leverone
Vermögen: 67 200 $ am 31.05.2026
Vermögen: 67 200 $ am 31.05.2026
Jason A. Leverone is currently Chief Financial Officer at OnKure Therapeutics, Inc. since 2024.
Former positions include Chief Financial Officer, Secretary & Treasurer at Viridian Therapeutics, Inc. from 2017 to 2021; Head-Finance & Operations at miRagen Therapeutics, Inc. from 2008 to 2012; Finance Director & Controller at Replidyne, Inc. from 2005 to 2009; Controller at CreekPath Systems, Inc. from 2002 to 2005; Principal at Ernst & Young LLP; Principal at KPMG LLP; Chief Financial Officer at OnKure, Inc.; and Audit Manager at Arthur Andersen LLP.
Education includes undergraduate studies at Bryant University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0,04 % | 01.04.2026 | 16.000 ( 0,04 % ) | 67 200 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|
| Unternehmen | Position | Ende |
|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Finanzdirektor/CFO | 14.05.2021 |
Replidyne, Inc.
Replidyne, Inc. BiotechnologyHealth Technology Develops and commercializes novel antibiotics to treat infections caused by drug resistant bacteria | Finanzdirektor/CFO | 01.02.2009 |
CreekPath Systems, Inc.
CreekPath Systems, Inc. Packaged SoftwareTechnology Services Provided storage management solutions | Comptroller/Controller/Auditor | 01.10.2005 |
OnKure, Inc.
OnKure, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing epigenetic therapies for the treatment of cancer | Finanzdirektor/CFO | - |
Arthur Andersen LLP
Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Comptroller/Controller/Auditor | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Replidyne, Inc.
Replidyne, Inc. BiotechnologyHealth Technology Develops and commercializes novel antibiotics to treat infections caused by drug resistant bacteria | Health Technology |
miRagen Therapeutics, Inc. /Old/
miRagen Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops microRNA-based therapeutics for cardiovascular and muscle diseases | Health Technology |
OnKure, Inc.
OnKure, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing epigenetic therapies for the treatment of cancer | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Arthur Andersen LLP
Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
CreekPath Systems, Inc.
CreekPath Systems, Inc. Packaged SoftwareTechnology Services Provided storage management solutions | Technology Services |
Bryant University
Bryant University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen